Medically assisted nutrition to assist palliative care patients
It is common for palliative care patients to have reduced oral intake during their illness. Management of this condition includes discussion with the patient, family and staff involved and may include giving nutrition with medical assistance. This can be done either via a plastic tube inserted into a vein directly or into the stomach or other parts of the gastrointestinal tract. It is unknown whether this treatment helps people to feel better or live longer. A search of the international literature was only able to find a small number of studies looking at this issue. As a result, it is not possible to clearly define the benefits and harms of this treatment.
B A C K G R O U N D
Many palliative care patients have a reduced oral intake during their illness. The cause of this varies, but may be part of a physical obstruction, anorexia/cachexia syndrome, generalised weakness, bowel obstruction, loss of desire to drink or no specific cause may be identified. The most common time for this decreased oral intake is during the terminal phase, when the patient becomes less conscious and therefore less able to receive nutrition orally (Morita 1998).
Management of this condition includes discussion with the patient, family and staff involved and either no medical intervention (but continued attention to treating any symptomatic problems, including good mouth care) or the provision of nutrition with medical assistance. The aim of this intervention can be to prolong the length of life of a participant, improve their quality of life, or both. These benefits may come via the reversal of the physiological factors associated with the patient's decline. Balanced against these potential benefits are adverse events that can be associated with any intervention (infection, bleeding, pain etc) (Bozzetti 1996) . It is also essential to assess the psycho-spiritual impact of undergoing the treatment and what their expectations of medically assisted nutrition are.
Medically assisted nutrition can be performed via a tube inserted into any part of the gastrointestinal system (enteral) or via a tube inserted into the venous system (parenteral). There is some controversy and views vary on the ethics of medically assisted nutrition (Casarett 2005) . The first ethical controversy centres around whether medically assisted nutrition is a medical intervention or a basic provision of comfort. Secondly there is controversy as to how and by whom should decisions be made with regards to medically assisted nutrition in patients who no longer have the capacity to make decisions for themselves. This review will concentrate on assessing the benefit of provision of nutrition with medical assistance versus the harm caused by such intervention in palliative care patients. It is only with this information that clinicians and patients can make informed decisions about whether this type of intervention is beneficial or harmful to an individual patient.
A separate Cochrane review has been conducted looking at the provision of medically assisted hydration for palliative care patients (Good 2008) .
O B J E C T I V E S
The objectives of this review are to determine the effect of medically assisted nutrition in palliative care patients on their quality and length of life.
M E T H O D S
Criteria for considering studies for this review
Types of studies
All relevant randomised controlled studies (RCTs) or prospective controlled studies (if no RCTs were found).
Types of participants

Participants included:
• palliative care participants who received medically assisted nutrition;
• those that were receiving palliative care (WHO 2005); • (but not be limited to) incurable cancer, dementia, neurodegenerative diseases (e.g. Motor Neuron Disease), Human Immunodeficiency Virus, Chronic Airways Limitation and Chronic Heart Failure whose prognosis was limited and the focus of care was quality of life (Doyle 2004;
• adult participants aged 18 years and above were included, both male and female and in any setting such as home, hospice or hospital.
Included participants were not limited to those in the terminal phase of their illness. Participants who were having medically assisted nutrition as part of a perioperative, chemotherapy or radiotherapy regime, or because of chemotherapy or radiotherapy adverse effects will be excluded.
Types of interventions
Medically assisted administration of nutrition:
• parenteral nutrition -administration of nutritional liquid via a central or peripheral venous catheter, that does not directly enter the gastrointestinal system;
• enteral nutrition -administration of nutritional liquid through a tube via the gastrointestinal system (nasogastric tube, jejunostomy, gastrostomy).
Comparisons:
• placebo, • no intervention, • usual treatment or supportive care.
Types of outcome measures
Primary outcomes
1. Quality of life on any measure (including symptom assessment scales)
Secondary outcomes
Survival 2. Adverse Events
Search methods for identification of studies
A. Electronic Databases
The following electronic databases were searched using a search strategy developed for MEDLINE, but modified appropriately for each database:
• The Cochrane Library: Cochrane Controlled Trials Register, Cochrane Database of Systematic Reviews, Cochrane Database of Reviews of Effectiveness.
• MEDLINE (1966 to present).
• EMBASE (1980 to present).
• CINAHL.
• CANCERLIT.
• Caresearch -database listing conference proceedings and grey literature.
• Dissertation abstracts.
• SCIENCE CITATION INDEX.
Date of most recent search: July 2008
B. Reference Lists
The reference lists of all eligible trials, key textbooks, and previous systematic reviews were searched for additional studies.
C. Language
The search attempted to identify all relevant studies irrespective of language. There were no non-English papers identified. The subject search used a combination of controlled vocabulary and free text terms based on the search strategy for searching MED-LINE. Please see Appendix 1. This search strategy was adapted for other databases searched.
Data collection and analysis
Studies identified by the search strategy had the title and abstract (where possible) assessed by the lead review author (PG) to identify potentially relevant articles. The results of studies identified from the different databases were as follows:
The Cochrane Library -1136 (476 from clinical trials) MEDLINE -6655 EMBASE -4548 CINAHL -56 CANCERLIT -2480 Caresearch -172 Dissertation abstracts -54 SCIENCE CITATION INDEX -4601 After review of the title and abstracts, 22 references were retrieved in full. Unfortunately none of these met the inclusion criteria. However, there were four prospective non-controlled trials (including one qualitative study), and a Cochrane systematic review. These studies will be described in the discussion section.
Quality
All studies were to have their methodological quality assessed. There was to be two scales used.
1. RCTs would be assessed via the Oxford Quality Scale devised by Jadad et al (Jadad 1996) .
2. The quality of non RCTs would be assessed using a scale devised by Rinck et al (Rinck 1997) .
Data extraction
The following information was planned to be obtained for each study:
• study methods (study design, allocation, blinding, setting, inclusion criteria);
• participants (sample size, exclusions/inclusions, number, disease, duration of trial, withdrawals and dropouts, site -e.g. hospital, hospice, home);
• intervention (type, route of delivery, control used);
• outcome (quality of life, symptom measures, survival, time from death intervention was initiated);
• adverse effects.
The extraction was to occur independently by two review authors.
Data analysis
The overall effectiveness of medically assisted nutrition in palliative care participants was to be assessed and also specific sub-group analysis (where possible) was to be undertaken by:
• study design:
data from RCTs and prospective controlled studies were to be evaluated separately
• participants:
• intervention:
• medically assisted nutrition -parenteral, enteral nutrition.
• study quality • timing of intervention (in relation to death) • site
Statistical analysis
No studies were suitable for evaluation.
R E S U L T S Description of studies
See: Characteristics of excluded studies. No studies met the inclusion criteria.
Excluded studies
Please see Table 1 in 'Additional tables' and the Characteristics of excluded studies table.
Risk of bias in included studies
No studies were evaluated for methodological quality.
Effects of interventions
There were no RCT nor prospectively controlled trials found that met the inclusion criteria.
D I S C U S S I O N
The objective of this systematic review was to determine the effectiveness of medically assisted nutrition in palliative care patients (of all ages) on their quality and length of life. Extensive searching of the literature produced no RCTs nor prospective controlled trials that fulfilled the inclusion criteria. The discussion will focus only on prospective trials that were retrieved, as this represents the next highest study quality design. However, the studies are all of a low quality because of their design, and therefore caution is needed in interpreting any of the results. In a prospective, cohort study of participants with advanced dementia there was no significant difference, in survival, between those participants with PEG inserted (median 195 days, range 21 to 1405 days), and those without PEG insertion (median 189 days, range four to 1502) (P = 0.9) (Meier 2001). The Cochrane review had conflicting results, in that three studies found a longer survival in participants who had a PEG, whilst the other four studies found no difference. Bozzetti 2002 found that participants on home parenteral nutrition (HPN) had a median survival of four months. The mean survival was used when Pironi 1997 looked at participants on HPN (12.2 weeks) and those on home enteral nutrition (17.2 weeks). QOL did not improve after PEG insertion for participants with motor neuron disease (Langmore 2006), nor at one month in those with advanced cancer (Bozzetti 2002), but there was a perceived benefit in this area in the qualitative study (Orrevall 2005) . In one study (Bozzetti 2002) the KPS was stable until a progressive decline at three months prior to death, whilst another study (Pironi 1997) found that at one month after intervention the KPS was increased in 13 participants, decreased in 19 participants, and was unchanged in 132 participants. The qualitative study of advanced cancer participants in Sweden (Orrevall 2005) found that HPN produced positive features including assurance that nutrition was being met, and this led to a perceived benefit on energy, strength and activity. It was also seen as decreasing the feeling of "pressure to eat" and more acceptance of whatever was able to be eaten orally.
Pironi 1997 found that with HEN, there was NG tube blockage/ dislodgment in 0.26 per year of HEN and PEG site infection in one participant and hub replacement in two participants, whilst the complications of treatment with HPN (per year of treatment were catheter sepsis (0.67), DVT (0.16) and metabolic instability (0.50). This study also attempted to look at the burden of medically assisted nutrition for participants and their families. However, this was only done as a judgement by nutrition staff, and was therefore open to a large element of bias. They found that medically assisted nutrition was well accepted in 124 cases (19 HPN), with annoyance in 30 cases (seven HPN), and scarcely tolerated in ten cases (three HPN). The qualitative study (Orrevall 2005) found that the negative features of HPN were related to physical symptoms of nausea, vomiting, drowsiness and headache, as well as HPN placing a restriction on their family life and social involvement.
A U T H O R S ' C O N C L U S I O N S Implications for practice
There are insufficient good quality studies to make any recommendations for practice with regards to the use of medically assisted nutrition in palliative care patients. Clinicians will need to make a decision based on the perceived benefits and harms of medically assisted nutrition in individual patient circumstances, without the benefit of high quality evidence to guide them. The uncontrolled prospective studies described would suggest that patients with a good performance status and medium to long term prognosis (months to years) may benefit from medically assisted nutrition. However, the evidence base to support this at the moment is weak and any intention to use this treatment should be monitored carefully and ideally fed in to further research.
Implications for research Trial design
There are very few quality studies that have looked at the question of medically assisted nutrition in palliative care patients. It may be difficult to ever do a RCT in this area. The logistics of recruiting participants to any palliative care trial are well known (Rinck 1997) but are especially so with regards to medically assisted nutrition. There are two distinct palliative care populations, in which further trials of the effect of medically assisted nutrition would be useful. The first is those patients who develop the anorexia/ cachexia syndrome. The second is in those patients who are unable to swallow, but whose prognosis (from their cancer) would seem to be longer than their prognosis from the aphagia. The difficulty in this situation is the reliance on the physicians ability to provide a prognosis, and this is not always accurate (Glare 2003).
As well as looking at the possibility of RCTs in this area, the evidence base will be improved with at least some prospective controlled trials, and even with more prospective uncontrolled trials. This may need to be done with innovative designs such as comparisons between different centres that have different nutrition practices or by following up cohorts of participants who are offered medically assisted nutrition, in whom some proceed and some do not (as long as the two groups are similar).
Patient groups
The studies in this review did not have well defined patient populations. Palliative care is performed in hospital, in-patient palliative care units and the community. Trials need to be performed in all these areas to allow external validity (able to be applied to a similar patients as those seen in a trial) to different palliative care populations. It would also be helpful to define at what stage of their illness participants are being given medically assisted nutrition. The reasons and aims of nutrition in the last few days/weeks of life may be very different to those participants with a longer prognosis. The prospective prediction of prognosis is difficult, and it may be better to stratify participants according to performance status.
Interventions
Medically administered nutrition can be given by many different routes. Further trials are needed to determine the optimum route and dose.
Outcomes
It is important that clinically relevant outcomes are clearly defined and are the most clinically useful to this situation. In this patient population this includes energy levels, functional status and overall quality of life. As well as these, the effect of this intervention on overall survival needs to be reported. Also important is that adverse events are well defined so that the risk of treatment can be balanced against any benefits.
D A T A A N D A N A L Y S E S
This review has no analyses. There were no RCTs found. The review discussed seven studies. Five of these studies were retrospective case controlled. Two were prospective cohort studies (Chio 2002 and Mazzini 1995) . All seven studies tested for survival advantage of intervention. Three found a longer survival in participants who had a PEG, whilst the other four found no difference. 
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